Skip to main content
Clinical Trials/NCT05485415
NCT05485415
Active, not recruiting
Not Applicable

Personalised Circadian Intervention Study in Elderly With Sleep Problems

Mirjam Münch1 site in 1 country66 target enrollmentJuly 15, 2022

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Sleep Disturbance
Sponsor
Mirjam Münch
Enrollment
66
Locations
1
Primary Endpoint
Subjective sleep quality
Status
Active, not recruiting
Last Updated
last year

Overview

Brief Summary

The main objective of the study is to improve subjective sleep quality using a multimodal intervention with an intervention and a control group. The multimodal intervention aims to improve circadian Zeitgeber strength. This will be achieved by optimizing daily light exposure, sleep, physical activity, and mealtimes.

Detailed Description

The study lasts for 14 months and contains 6 visits. After the screening visit at the Centre for Chronobiology, Basel, Switzerland, participants are assigned to either the intervention or the control group which is followed by a 7-day baseline week at home and a co-design meeting to provide instructions to the intervention and the control group. At the occasion of 2 visits (spread over 6 months) at the participants' homes, different measurements will be performed such as saliva collection, questionnaires, cognitive performance tests, light and rest-activity measures. After the last visit at home, participants come for the second blood sample at the study centre. A follow-up visit 6 months after completion of the last data collection will provide qualitative feedback by the participants.

Registry
clinicaltrials.gov
Start Date
July 15, 2022
End Date
July 31, 2025
Last Updated
last year
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
Mirjam Münch
Responsible Party
Sponsor Investigator
Principal Investigator

Mirjam Münch

Principal Investigator

University Psychiatric Clinics Basel

Eligibility Criteria

Inclusion Criteria

  • at least 65 years old women and men
  • Pittsburgh Sleep Quality Index (PSQI) \> 5 (indicative of sleep problems)
  • Living at home (including self-serviced retirement apartment)

Exclusion Criteria

  • Total blindness or VA \< 0.5
  • Progressive NCDs (e.g., cancer)
  • Acute infections (e.g., Covid-19)
  • Neurodegenerative disease
  • Psychiatric disease
  • Sleep disorder (sleep apnea, narcolepsy)
  • Not German speaking

Outcomes

Primary Outcomes

Subjective sleep quality

Time Frame: 6 months

Pittsburgh Sleep Quality Index (Score \> 5 indicates poor sleep)

Secondary Outcomes

  • Sleep timing(6 months)
  • Salivary melatonin concentration(6 months)
  • Neuropsychological Battery to assess working memory and attention (including n-back, Psychomotor Vigilance Test)(6 months)
  • Pupil size(6 months)
  • Glucose metabolism(6 months)
  • Telomere length(6 months)
  • Subjective wellbeing(6 months)

Study Sites (1)

Loading locations...

Similar Trials